Table Of ContentSTATISTICS IN MEDICINE VOL. 16, 2941-2943 (1996)
AUTHOR INDEX
Aalen, O. O., 2191 Chuang-Stein, C., 2599 Fleming, T. R., 1515
ACSF Investigators, 397 Clark, I., 1745 Fuerst, T. P., 1889
Agresti, A., 2599 Clark, L. C., 853
Aickin, M., 1845 Cnaan, A., 2349 Gail, M., 133
Akazawa, K., 583 Commenges, D., 1283 Gamel, J. W., 1629
Andersen, P. K., 215 Connelly, R. R., 1401 Gao, S., 783, 2049, 2419
Anderson, S., 44i Cook, P., 321 Gatsonis, C., 2311
Ashby, D., 1413 Cook, R. J., 911 Gee, L., 441
Austin, H., 1005 Coste, J., 561 Gefeiler, O., 981, 1107
Couper, D., 1551 Genant, H. K., 1889
Bacchetti, P., 645 Crichton, N. J., 717 Gilks, W. R., 741
Bailey, N. T. J., 2447 Cui, J.-S., 2339 Gill, O. N., 2191
Barai, U.,.941 Cuzick, J., 1017 Gill, R., 39
Becher, H., 993 Glidden, D. V., 833
Becker, N. G., 2339 Dain, B., 1943 Glynn, R. J., 357
B,l isle, P., 769 Daniels, M. J., 1965, 2311 Goldberg, R., 1311
Benichou, J., 133 Dartiques, J., 1283 Goldbourt, U., 1873
Bennett, C. L., 1451 Davidian, M., 1765 Gonin, R., 1925
Bernardinelli, L., 741 Davis, C. E., 2009 Gordon-Salant, S., 2475
Best, N. G., 741 Day, N. E., 2191 Gore, S. M., 2459
Betensky, R. A., 465, 2429, De Angelis, D., 2191 Gray,J .C ., 1481
2587 De Angelis, R., 425 Greenland, S., 515
Biggerstaff, B. J., 753 De Gruttola, V., 1515 Greenwood, C. M. T., 545
Biscay, R., 1745 Dear, K. B. G., 2177 Grill, S. E., 2245
Bixler, E. O., 1995 Deville, J.-C., 397 Gu, C., 1357
Bjorling, L. E., 1175 Dey, D. K., 1817
Blood, J., 681 Diehr, P., 1211 Haber, M., 601
Bois, F. Y., 441 Dobson, A. J., 2177 Hadgu, A., 1391, 2403
Boyett, J. M., 2095 Donner, A., 1097, 1753 Hakulinen, T., 2297
Brant, L. J., 2475 Drescher, K., 117 Hall, W. J., 2143
Brenner, H., 981 Du Berger, R., 769 Halpern, J., 153
Breslow, N. E., 103 Dubey, S. D., 2529 Hamilton, S. A., 2029
Brettle, R. P., 2459 Dunnett, C. W., 2489 Hanrahan, J. P., 1603
Brittain, E., 681 Dunstan, F. J., 1481 Hardy, R. J., 2063
Broemeling, L. D., 321 Dyba, T., 2297 Hashemi, L., 1311
Brookmeyer, R., 1983 Hauck, W. W., 441, 545,
Brown, B. W., 2511 Edwards, R., 1017 1683
Brown, E. B., 803 Eliasziw, M., 1097 Heijde, D. van der, 1653
Bull, K., 1041 Elswick, R. K., Jr., 1695 Heinze, G., 73
Bull, S. B., 545 Erkanli, A., 1121 Heitjan, D. F., 347, 1791
Byrne, C., 133 Etzioni, R., 627 Hinde, J. P., 717
Hodges, J. S., 1175
Cai, J., 2009 Fairclough, D. L., 1197 Hogan;J . W., 239, 259
Capocaccia, R., 425 Faraggi, D., 2573 Holubkov, R., 103
Carey, V. J., 1667 Farewell, V. T., 2191 Hosmer, D. W., 965
Carroll, R. J., 169 Fatti, L. P., 333 Hosmer, T., 965
Carter-Campbell, S., 695 Fay, M. P., 791, 2389 Hughes, M. D., 865, 1965
Catalano, P. J., 883 Fayers, P. M., 1413 Hui, S., 1889
Chen, L., 1167 Feuer, E. J., 791, 2389 Hui, S. L., 2419
Chen, R., 1401, 1873 Fick, G. H., 373, 2103 Huque, M. F., 2529
Chow, S.-C., 1031 Finkelstein, D. M., 951 Hyslop, T., 441
2942 AUTHOR INDEX
Iscovich, J., 1873 Marchini, J., 717 Romano, P. S., 1301(L)
Iyer, H. K., 803 Marshall, R., 2022(L) Romanowski, B., 2103
Martin, D. O., 1005 Rose, M. S., 373, 2103
Jacqmin-Gadda, H., 1283 Martinussen, T., 273 Rosenberger, W. F., 2245
Jereb, J. A., 485 Mathews, J. N. S., 705 Rosner, B., 357
Jiang, W., 853 Mathur, A. K., 1889 Rotnitzky, A., 81
Jim,nez, J. C., 1745 Matsuyama, Y., 1587 Russek-Cohen, E., 455
Johnson, W. D., 1081, 2127 Matts, J. P., 1943 Russell, K., 2511
Jones, B., 1955 May, W. L., 1081, 2127
Joseph, L., 769 Mehrotra, D. V., 1465 Sankoh, A. J., 2529
Meier, K. L., 1337 Schemper, M., 73
Kaiser, M. S., 1151 Meisner, M., 2211 Schill, W., 117
Keiding, N., 215, 273 Messiah, A., 397 Schmoor, C., 225
Klar, N., 1753 Meyer, L., 397 Schoenfeld, D. A., 951
Klein, B., 1357 Mian, I. U. H., 1497 Schumacher, M., 225
Klein, J. P., 215 Miller, C., 1943 Schwartz, P. F., 1695
Klein, R., 1357 Milner, P. C., 2117 Scott, A. J., 1377
Klerk, E. de, 1653 Morrell, C. H., 2475 Seaman, S. R., 2459
Knapp, R. G., 1705 Moy,, L. A., 2267 Segal, M. R., 1603
Koch, G., 2403 Segnan, N., 1017
Kiichenhoff, H., 169 Nakamura, T., 583 Senn, S., 1303(L), 2021(L)
Kuha, J., 189 Nandram, B., 1311 Shao, J., 1031, 1167
Neely Atkinson, E., 1803 Shapiro, D. E., 2143
Lachin, J. M., 653 Nejjari, C., 1283 Sharma, D., 347
Lagakos, S. W., 925 Nelson, E. T., 1943 Shen, Y., 627
Laird, N. M., 239, 259, 2349 Neuh,,user, M., 993 Shih, W. J., 1225, 1913
Langer, S. F. J., 1617 Ng'andu, N. H., 611 Shoukri, M. M., 1497
Larose, D. T., 1817 Nix, A. B. J., 1481 Siev, D., 1151
Laska, E. M., 2211 Simon, R., 2573
Lau, T. S., 2283 Obuchowski, N. A., 1529 Simon, R. M., 455
Launer, C. A., 1943 Ohashi, Y., 1587 Slasor, P., 2349
Lawless, J. F., 911 Smith, P. J., 485
Lazaridis, E. N., 1925 Paivarinta, L., 2297 Soltysik, R. C., 1451
Le Cessie, S., 965 Palensky, J., 681 Soyer, R., 1121
Leblond, L., 203 Palesch, Y., 583 Spiegelhalter, D. J., 1041
Lee, A. J., 1377 Pan, G., 1645 Sposto, R., 695
Lee, S. Y., 1859 Park, T., 1859 Stablein, D., 695
Lee, W.-C., 729 Parmar, M. B., 1413 Stamenovic, E., 951
Leisenring, W., 1263 Pascutto, C., 741 Stangl, D., 1121
Lele, C., 2543 Patrick, D. L., 1211 Strémberg, U., 2327
Lellouch, J., 397 Pearson, J. D., 2475 Sun, J., 497
Lemeshow, S., 965 Pepe, M., 5
Li, Q. H., 925 Pepe, M. S., 1263, 1551 Tager, I. B., 1603
Li, Y., 2095 Perkins, L. L., 1005 Tamhane, A. C., 2489
Lin, D. Y., 901, 1515 Pichlmeier, U., 1107 Tang, D.-I., 2211
Linden, S. van der, 1653 Pitard, A., 527 Tango, T., 2621(L)
Lindsey, J. K., 1955 Psaty, B. M., 1211 Ten Have, T. R., 1995
Liu, Q., 711(L), 2095 Puterman, M. L., 2177 Teoh, N., 941
Longton, G., 1263 Pyke, S. D. M., 2063 Terry Beirn Community
Love, E. J., 2103 Programs for Clinical
Lu, Y., 1889 Quan, H., 1225 Research on AIDS, 1943
Lui, K.-J., 1777 Therneau, T. M., 2029
Reilly, M., 5 Thompson, M. L., 333
McClish, D. K., 1529 Reynolds, T., 1481 Thompson, S. G., 2063
McKee, L. J., 1683 Richardson, S., 203 Thompson, T. J., 485
Mackenzie, G., 1831 Ritov, Y., 285 Tibshirani, R., 385
McMurchy, L., 1377 Robins, J., 81 Tierney, C., 2587
McNeil, A. J., 2555 Robins, J. M., 21, 39, 285 Torrance-Rynard, V. L., 2157
McShane, L. M., 1337 Roe, D. J., 1241 Tretli, S., 1435
Mantel, N., 1401 Rogerson, P. A., 2081 Turnbull, B. W., 853
AUTHOR INDEX
Turner, B. J., 1683 Walker, S., 1135 Wittes, J., 681
Tweedie, R. L., 753 Wallenstein, S., 1329 Wolfe, D. A., 1645
Walsh, S. J., 669 Xie, T., 1845
Umbach, D. M., 1731 Walter, E., 561 Xue, X., 1983
Urquhart, J., 1653 Walter, S. D., 2157
Wang, C. M., 803 Yarnold, P. R., 1451
Vacek, P. M., 505 Wang, Y., 1357 Ye, K., 1889
Vach, W., 57 Warszawski, J., 397
Varga, P., 821(L) Wasserman, D., 561
Venot, A., 561 Wassermann, E. M., 1337 Zackin, R., 571
Viel, J. F., 527 Wei, L. J., 571, 833 Zahl, P.-H., 1435, 1573
Vogel, R. L., 1629 Weinberg, C. R., 1731 Zeng, Q., 1765
Voit, E. O., 1705 Welsh, J. A., 1695 Zhao, P.-L., 1913
Vuorinen, J., 2229 Westrom, L., 2403 Zhou, H., 1301(L), 2009
White, I. R., 2619(L) Zhou, X., 783
Wahba, G., 1357 Whittemore, A. S., 153, 2543 Zhou, X.-H., 2049
Wakefield, J., 1135 Wight, S., 1603 Zou, K. H., 2143
STATISTICS IN MEDICINE, VOL. 16, 2945-2962 (1997)
SUBJECT INDEX“
Notes: Single page numbers refer to individual papers. The page ranges shown indicate collections of
papers on particular subjects. (L) after some page numbers identifies letters.
Accident and emergency Almon’s method, 527
forecasting models, 2117 Analysis of variance
longitudinal study, 2928 F tests, 2729
Accrual buffers, 1925 intraclass correlations, 1497
Accuracy smoothing spline methods, 1357
clinical trials, 705 Anderson-Gill model, 2029
indices ROC curves, 1529 Anginal attacks, 1955
Adenomatous polyps, 1845 Antigens, 1151
Adjustment non-parallel immunoassay curves, 1151
multiple endpoints, 2529 Antiretroviral therapy
Age rule-based ranking schemes, 1175
breast cancer, 133, 1435 ARIMA see Autoregressive integrated moving
data-dependent interval partition, 1617 averages
Age-specific rates Artherosclerosis see Coronary artery disease
reference intervals, 2785 Assays
AIDS (Acquired immunodeficiency syndrome) cell dilution, 571
see also CD4 lymphocyte counts; HIV Association
asymptotic period, 627 continuously monitored strategy, 1925
clinical trials Asthma
endpoint, 951, 1175 treatment divergence, 2855
surrogate markers, 1515, 1965 Asymptotic confidence intervals, 1329
cumulative incidence function, 901 Asymptotic relative efficiency, 117
delay data, 2339 Attributable risk
follow-up losses, 1943 Bayesian inference, 1311
incidence, 645 epidemiology, 729
longitudinal studies, smooth curves, 2429 recurrent disease events, 1107
Markov model analysis, 2191 risk factor prevalence, 2543
pneumonia, 1451 Autoregressive integrated moving average models
Air pollution, 2928 accident and emergency attendances, 2117
Alcoholism reparametrization, 1745
diagnosis test, 1695
Algorithms Backcalculation
see also Expectation maximization algorithm; HIV diagnosis, 2191
Markov Chain Monte Carlo algorithm Baseline measurements
CODA, 285 biased baseline rates, 1401
LABROC4, 2143 heterogeneity, 2883
Metropolis-Hasting algorithm, 1817 Bayesian inference
ROC & ROL, 2143 autocorrelated errors, 321
Allocation ratio sample size calculation, 2805 binomial proportions, 1311
* Compiled by INDEXING SPECIALISTS, 202 Church Road, Hove, East Sussex, BN3 2DJ, U.K.
2946 SUBJECT INDEX
Bayesian inference (cont.) Bladder cancer, 865
CODA asymptotic theory, 285 Blinded subjective ranking
dose determination, 1135 treatment effect, 681
hierarchical models Blood pressure
disease maps, 741 intraclass correlations, 1497
variability analysis, 2311 missing data, 2713
immunological progression rates, 2555 BMDP computer package
independence models, chest pain diagnosis, 717 mixed models, 2349
measurement errors, 203 Bone marrow
meta-analysis, 1817 transplants
persuasion probability, 1791 busulfan concentrations, 2095
proportional hazards model, 2573 continuous monitoring, 1925
sample sizes, 769 graft-versus-host disease, 1551
treatment evaluation, 1803 Bone mineral density, 1889
two-phase prevalence studies, 1121 Book reviews
underlying risk, 2741 Agresti, A., An Introduction to Categorical Data
Bayesian monitoring scheme Analysis, 2383
interim analysis, 1413 Arminger, G., Clogg, C. C. and Sobel, M. E.,
Bayes’ theorem, 1413 Handbook of Statistical Modeling for the
Beta-binomial model, 2849 Social and Behavioural Sciences, 1433
Bias Armitage, P. and David, H. A., Advances in
baseline rates, 1401 Biometry, 2137
cutpoint model, 2813 Baker, F. B., Item Response Theory. Parameter
diagnostic tests, 1391 Estimation Techniques, 2261
measurement error, 169 Bell, F. D., Basic Statistics: Concepts for the
model misspecification, 669 Health Sciences: The Almost No Math Stats
observational studies, 1041 Book, 1307
reduction, 545 Beolchi, L. and Kuhn, M. H., Medical Imaging-
Binary response Analysis of Multimodality 2D/3D Image,
correlated data, 1081, 2127 2630
double-blind clinical trials, 1913 Berry, D. A. and Stangl, D. K., Bayesian
mixed effects models, 1587 Biostatistics, 1655
randomized clinical trials, 1017 Bishop, C. M., Neural Networks for Pattern
recurrent disease events, 1107 Recognition, 2385
teratologic studies, 2843 Blond, M., An Introduction to Medical Statistics,
two-stage data, 103 2262
Binary screening tests, 2282 Bowers, D., Statistics from Scratch: An
Binormal model ROC analysis, 669 Introduction for Health Care Professionals,
Bioassays 2932
non parallel dose-response curves, 1151 Breen, R., Regression Models: Censored,
Bioavailability Sample-Selected, or Truncated Data,
bioequivalence, 803, 2229 1789
replicate crossover designs, 1031 Buncher, C. R. and Tsay, J. Y., Statistics in the
Biochemical markers, 1481 Pharmaceutical Industry (2nd edn), 1909
Bioequivalence Busby, C., Wings of Death: Nuclear Pollution
higher-order cross-over designs, 1031, 2229 and Human Health, 2025
individual, 803 Campbell, M. J. and Swinscow, T. D. V.,
population, 441 Statistics at Square One, 2629
Biographies Carroll, R. J., Ruppert, D. and Stefanski, L. A..,
Semmelweis, I. P., 2767 Measurement Error in Nonlinear Models,
Biostatistics 2628
future trends, 2773 Chalmers, I. and Altman, D. G., Systematic
Birthweight Review, 2929
logistic regression model, 965 Chatfield, C., The Analysis of Time Series - An
maternal smoking, 1603 Introduction, 2386
Bivariate data Cleveland, W. S., The Elemants of Graphing
discriminant analysis, 2679 Data, 481
power approximation, 865 Clogg, C. C. and Shihadeh, E. S., Statistical
SUBJECT INDEX 2947
Models for Ordinal Variables. Advanced Kleinbaum, D. G., Survival Analysis: A Self-
Quantitative Techniques in the Social Learning Text, 2934
Sciences 4483 Knapp, T. R., Learning Statistics Through
Coggon, D., Statistics in Clinical Practice, 1193 Playing Cards, 1543
Cooper, H. and Hedges, L. V., The Handbook of Kreienbrock, L. and Schach, S.,
Research Synthesis, 713 Epidemiologische Methoden, 829
Corter, J. E., Tree Models of Similarity and Krzanowski, W. J., Recent Advances in
Association, 1546 Descriptive Multivariate Analysis, 1787
Di Rienzo, M., Mancia, G., Parati, G., Pedotti, Lange, N., Ryan, L., Billard, L., Brillinger, D.,
A. and Zanchetti, A., Computer Analysis of Conquest, L. and Greenhouse, J., Case
Cardiovascular Signals, 1195 Studies in Biometry, 963
Eerola, M., Probabilistic Causality in Lehtonen, R. and Pahkinen, E. J., Practical
Longitudinal Studies, 2761 Methods for Design and Analysis of
Esteve, J., Benhamou, E. and Raymond, L., Complex Surveys, 482
Statistical Methods in Cancer Research. McNeil, D., Epidemiological Research Methods,
Vol IV. Descriptive Epidemiology, 715 2381
Everitt, B. S., The Cambridge Dictionary of Manton, K.G., Woodbury, M. A. and Tolley,
Statistics in the Medical Sciences, 1910 H.D., Statistical Applications Using Fuzzy
Feinstein, A. R., Multivariate Analysis: An Sets, 1789
Introduction, 2382 Marubini, E. and Valsecchi, M. G., Analysing
Finkel, S. E., Causal Analysis with Panel Data, Survival Data from Clinical Trials and
1547 Observational Studies, 2138
Fischer, G. H. and Molenaar, I. W., Rasch Matthews, J. R., Quantification and the Quest for
Models. Foundations, Recent Developments Medical Certainty, 1908
and Applications, 1431 Meinert, C. L., Clinical Trials Dictionary:
Forthofer, R. N. and Lee, E. S., Introduction to Terminology and Usage Recommendations,
Biostatistics. A Guide to Design, Analysis, 1911
and Discovery, 1075 Mollison, D. (ed), Epidemic Models: Their
Gabler, E., Biometrische Methodik Structure and Relation to Data, 1666
Pharmakologischer Tierexperimente, 2139 Moore, T. J., Deadly Medicine: Why Tens of
Glasbey, C. A. and Horgan, G. W., Image Thousands of Patients Died in America’s
Analysis for the Biclogical Sciences, 2759 Worst Drug Disaster, 2507
Goldstein, H., Multilevel Statistical Models (2nd O’Hagan, A., Kendall’s Advanced Theory of
edn), 1309 Statistics. Volume 2B, 1907
Grayson, Lesley, Scientific Deception: An Paling, J., Up To Your Armpits in Alligators?
Overview and Guide to the literature How To Sort Out What Risks Are Worth
of Misconduct and Fraud in Scientific Worrying About!, 2929
Research, 599 Parmar, M. B. K. and Machin, D., Survival
Greenwood, P. E. and Nikulin, M. S., A Guide to Analysis: A Practical Approach, 714
Chi-squared Testing, 2263 Peto, R., Lopez, A. D., Boreham, J., Thun, M.
Haccou, P. and Meelis, E., Statistical Analysis of and Heath, C. Jr., Mortality from Smoking
Behavioural Data - An Approach Based on in Developed Countries, 1544
Time-structured Models, 1079 Rasch, D., Tiku, M. L. and Sumpf, D., Elsevier’s
Hampton, R. E., Introductory Biological Dictionary of Biometry, 1080
Statistics, 1308 Rees, D. G., Essential Statistics for Medical
Hand, D. and Crowder, M., Practical Practice - A Case-Study Approach, 1194
Longitudinal Data Analysis, 2026 Selvin, Steve, Practical Biostatistical Methods,
Hayduk, L. A., LISREL - Issues, Debates, and 600
Strategies, 1911 Sloan, M. D., Using Designed Experiments to
Hill, C., Com-Nougué, C., Kramar, A., Moreau, Shrink Health Care Costs, 2627
T., O’Quigley, J., Senoussi, R. and Stapleton, J. H., Linear Statistical Models, 1076
Chastang, C., Analyse Statistique des Strike, P., MEDSAP. A Statistical Toolkit for
Données de Survie, 1550 Health Professionals Version 22265
Hoch, J. C. and Stern, A. S., NMR Data Thall, P., Recent Advances in Clinical Trial
Processing, 2935 Design and Analysis, 1077
Isham, V. and Medley, G., Models for Infectious Utts, J. M., Seeing Through Statistics, 2931
Human Diseases: Their Structure and Venables, W. N. and Ripley, B. D., Modern
Relation to Data, 1545 Applied Statistics with S-PLUS, 1548
2948 SUBJECT INDEX
Book reviews (cont.) Carryover effects
Verma, B. L., Shukla, G. D. and Srivastava, R. replicate crossover designs, 1031
N., Biostatistics: Perspectives in Health CART see Classification and regression tree. . .
Care Research and Practice, 825 Case-control studies
Viertl, R., Statistical Methods for Non-Precise colorectal cancer, 1845
Data, 1194 data re-using, 1377
Wallgren, A., Wallgren, B., Persson, R., Jorner, early stopping, 2327
U. and Haaland, J-A., Graphing Statistics genotype/exposure independence, 1731
and Data, 2760 meta-analysis, 1005
Weir, B. S., Human Identification: The Use of post-hoc stratification, 993
DNA Markers, 828 relative attributable risk, 2543
Bootstrap two-stage methods, 103, 117, 133
directly standardized rates, 791 Categorical data
log-normal means, 783 latent variable model, 883
resampling technique, 2813 CD4 lymphocyte counts
Breast cancer see also AIDS; HIV
asymptomatic period, 627 HIV, marker, 1965
chemotherapy trials, 1629 pre-AIDS mortality, 2459
DNA flow cytometry, 2813 progression rates, 2555
exposure-specific rates, 133 Centile estimates
long-term survival, 1435 multivariate approach, 333
prognostic markers, 2573 Change-score analysis, 1211
quality of life analysis, 1197 Chemotherapy
radiation effect, 21, 39 chemoimmunotherapy trial, 11803
Breast implants, 1005 survival analysis, 1629
British Family Heart study, 2063 Chest conditions
Bronchitis pain diagnosis, 717
dust concentration, 169 Chlamydia trachomatis, 1391
BUGS computer package, 2741 Cholesterol
Burkitt’s lymphoma, 2081 repeated measurements analysis, 653
Chronic diseases
CABG see Coronary artery bypass grafting non-fatal recurrent events, 1831
Calcium level, 1587 recurrent/terminating events, 911, 925
Calibration Classification
comparative study, 1889 method comparison studies, 705
immunoassay curves, 1765 optimal discriminant analysis, 561, 1451
CAN see Consistent and asymptotically normal. . . Classification and regression tree (CART)
Cancer technique, 717
see also Breast cancer Classification tree analysis (CTA), 1451
asymptomatic period, 627 Clinical trials
Bayesian interim analyses, 1791 see also Randomization; Stopping rules
case-control studies, 993 AIDS, failure time, 951
data monitoring, 1413 Bayesian analysis, monitoring, 1413
incidence prediction, 2297 binary response studies, 1913
mortality, occupational, 505, 515 contamination, 1017
phase III clinical trials, 1845 continuous monitoring strategy, 1925
prevalence, 425 data monitoring, 1413
quality of life assessment, 1197 drop-outs, treatment comparison, 1225
survival analysis, excess hazards, 1573 endpoints study, 1175, 1197, 2267
three-stage designs, 2701 follow-up losses, #943
Canonical systems, 1705 health status, 1197, 1211
Cardiac data processing, 1617 heterogeneity, 583, 2009
Cardiology HIV, recurrent/terminating events, 925
variability analysis, 2311 incomplete covariate data workshop, 1-319
Cardiovascular diseases interval-censored data, 497
clinical trials, 2267 losses to follow-up, 1943
risk, frailty model, 1983 multiple endpoints, 2529
risk factors, 1983 multiple events data, 833-951
SUBJECT INDEX
multivariate time-to-event data, 865 Computers
phase II correlated data analysis, 2349
Bayesian interim analysis, 1791 observational studies, 1667
three-stage design, 2701 Conditional models
stopping rules, 465, 1925 ectopic pregnancy, 2403
treatment efficacy, 1017 measurement errors, 203
treatment interaction, 1645 Conditional power calculations, 465
Cluster analysis Confidence intervals
bivariate model, 883 binomial proportions, 1329
leukaemia, 1873 correlated proportions, 2127
naturally ordered individuals, 1617 directly standardized rates, 791
teratologic studies, 2843 first event ocurrence, 711-712(L)
Cluster randomization log-normal means, 783
community interaction trials, 1753 longitudinal studies, 2429
mean hazard ratio parameters, 2009 qualitative interaction test, 1645 ‘
meta-analysis, 2063 quality performance index, 1301—1303(L)
CODA see Curse of dimensionality. . . treatment evaluation, 1017
Cohort studies vital rates, 2389
two-stage sampling, 133 Confounders
Collinearity logistic regression model, 993
pollutants/climatic conditions, 527 Confounding
Colorectal cancer attributable risk, 1107
adenomatous polyps ocurrence, 1845 Connective tissue disease, 1005
Combination Consistent and asymptotically normal estimators
across study designs, 1005 (CAN), 81
treatments, 2211 Contamination
Community interventions fish, 2327
pair-matched design, 1753 soils, 1167
Community Programs for Clinical Research on Continence status, 1859
AIDS, 1175 Contingency tables
Comparative calibration model, 1889 dose-response studies, 2599
Comparative studies Continuation ratio model
binomial probabilities, 1329 ordinal responses, 2873
discordant classification, 705 Continuity correction
dropouts, 1225 confidence intervals, 1329
goodness-of-fit tests, 965 exact equivalence tests, 1777
proportional hazards assesment, 611 Yates’, 1329
quality of life trials, 1197 Continuous confounders case-control studies, 993
sets/cuscore techniques, 1401 Continuous data
spatial prediction techniques, 1337 multivariate analysis, 883
treatment effects, 1645 sample size, 2805
variance components estimators, 1465 Continuous exposures, 729
Competing risks Continuous monitoring, 1925
cumulative incidence functions, 901 Coronary artery bypass grafting (CABG), 2645,
mortality, multivariate data, 951 2829
Complete cases Coronary artery disease
estimates, 57 statistical models, 2829
Complex survey data, 2419 Corrections
Compliance multiple testing, 2511, 2529
drug dosing histories, 1653 Corrections to published papers, 479, 480, 1299-
randomized clinical trials, 1017 1300, 2927-8
Computer packages Correlated frailty model, 1573
see also SAS... Correlations
goodness-of-fit, 965 binomial proportions, 1081, 1587, 2127
MEMS, 1653 generalized linear mixed model, 2349
multivariate failure time data, 2049 geographical distribution, 1283
NONMEM, 1135, 1241 intraclass coefficient, 821-823(L)
SPSS-PC, 1041 measurement errors, 2177
2950 SUBJECT INDEX
Cortical maps, 1337 interval censoring, 485, 497
Counting process longitudinal, 239, 259, 273, 2429
recurrent event analysis, 2029 net-work based mapping, 1667
Covariates skewness, 2785
incomplete data survival analysis, 1629
drop-outs, 239, 259, 273 validation, 189, 203
hot-deck multiple imputation, 5 Data monitoring committees (DMCs)
measurement errors, 169, 189, 203, 741, 853 interim analyses, 1413
multi-stage studies, 153 Data re-using, 1377
non-response models, 21, 39, 81 Decision thesholds, 669
prognostic factors, 57, 73, 225 Delay distribution, 2339
two-stage studies, 103, 117 Dementia studies, 2419
logistic regression, 1695 Depression
missing values, complex survey data, 2419 prevalence in adolescents, 1121
multivariate failure time data, 2049 Designs
Coverage probability see also Two-stage design
continuity correction, 1329 paired cluster randomization, 2063
mean confidence intervals, 783 phase II trials, 2701
Cox proportional hazards model tolerance intervals, 803
see also Non-proportional hazards model Detection rates screening, 1481
canonical system derivation, 1705 Developmental toxicity studies, 883
confidence intervals, 783 Diabetes
heterogeneity, 583 cortical cataract, 357
incomplete covariate data, 21, 73, 225 disease mapping, 741
multiple event data, 951 retinopathy, risk factors, 1357
multivariate failure time, 833 Diagnosis
multivariate time-to-event data, 865 AIDS, Markov model, 2191
proportional hazards assumption, 611, 1831 alcoholism, 1695
surrogate marker, 1515 CART methodology, 717
variable selection, 385 clustering, 1873
CPCRA see Community Programs for Clinical tests
Research on AIDS accuracy, 1529
Cross-validation bias effect, 1391
cutpoint model, 2813 dependent errors, 2157
Crossover trials disease, prevalence estimation, 981
bioequivalence study, 803 marginal regression model, 1263
higher-order designs, 2229 model misspecification, 669
phase III, 2021-2022(L) ROC curves, 2143
treatment comparisons, 1031 Diet
treatment-patient interactions, 1955 risk factors reduction, 2127
CTA see Classification tree analysis Directly standardized rates, 791
Cumulative incidence Discrepant analysis, 1391
AIDS, 2459 Discrete time survival data, 1983
competing risks, 901 Discriminant analysis
Cumulative meta-analyses, 2901 classification tree analysis, 1451
Cumulative sum method ordinal responses, 561
surveillance, spatial patterns, 2081 sum of binary variables, 2679
Curse of dimensionality appropiate (CODA) Diseases
asymptotic theory, 285 mapping, 741, 2773
Cuscore technique DNA
biased baseline rates, 1401 amplification tests, 1391
Cytomegalovirus disease, 1263 U.S. blacks genes, 153
Dose
Data augmentation, 189, 653 data analysis, 1653
Data collection Dose-response
clustering, 357 initial dose selection, 1135
failure time, 215, 259, 497, 833, 841 non-parallel immunoassay curves, 1151
follow-up data, 2773 ordinal responses, 2599
